BRIEF

on BIOSYNEX (EPA:ALBIO)

Nathalie Roos joins the Board of Directors of BIOSYNEX

Stock price chart of BIOSYNEX (EPA:ALBIO) showing fluctuations.

BIOSYNEX SA has announced the appointment of Nathalie Roos as an independent director, a decision that will be submitted for ratification at the next Annual General Meeting. Nathalie Roos brings over 35 years of experience in global organizations. She has held senior management positions at Mars, L'Oréal, and CVC Capital Partners. Her expertise includes business transformation, operational optimization, and sustainability.

Roos is committed to equal opportunity initiatives such as Women First and Will Society. She believes that businesses can generate a lasting societal impact. Larry Abensur, CEO of BIOSYNEX, believes her arrival strengthens the company's governance. BIOSYNEX's next financial communication is scheduled for April 22, 2026.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all BIOSYNEX news